Patients with tumors in the trigone and urethra were more likely to experience recurrence and cancer-specific death after radical cystectomy than patients with tumor only in the bladder walls. The ...

Second-line treatment of neurogenic bladder typically consists of a botulinum toxin-A (BTX-A) injection directly into the detrusor. New data, however, from a study carried out by Taha Abdel-Meguid at ...

Trigone Pharma Ltd. is a privately-held specialty pharmaceutical company focused on the development of a proprietary sustained-release platform designed to enhance the efficacy and safety of ...

Overactive bladder, or OAB, is a medical condition characterized by increased urgency to urinate, increase frequency of urination, incontinence or poor bladder control and frequent nighttime urination ...